Protein Sciences Corporation

Jun 15, 09
	NEW STORY
09:00 ET	Commercial Manufacturing of H1N1 'Swine Flu' Vaccine Underway
Apr 30, 09
15:55 ET	Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions
09:16 ET	Protein Sciences Corporation Appoints New Board of Directors
Oct 24, 08
10:57 ET	Vaxine Makes Unsolicited Bid to Acquire U.S. Company Protein Sciences Corporation
Jul 29, 08
13:32 ET	Protein Sciences Announces Termination of Deal to Sell to Emergent BioSolutions
Jul 10, 08
14:52 ET	Protein Sciences Responds to Emergent BioSolutions Lawsuit
Aug 29, 06
10:12 ET	Protein Sciences Announces Licensing of FluBlOk(TM) to UMN Pharma for the Japan Market
Jan 09, 06
00:01 ET	Protein Sciences Announces Closing of $6 Million Financing and Partnership in Diabetes Vaccine
Jun 14, 05
16:02 ET	Protein Sciences Announces Excellent Efficacy Results for FluBlOk(TM), its Recombinant Influenza Vaccine